Clinical Behavior and Treatment Response of Epstein‐Barr Virus‐Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials

Background Epstein‐Barr virus (EBV)‐positive gastric cancers (GCs) have been recently identified as a molecular subgroup showing excellent outcomes after surgery for early‐stage disease and responsiveness to immune checkpoint inhibitors (ICIs) for metastatic stage. No data are available on the preva...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2020-09, Vol.25 (9), p.780-786
Hauptverfasser:	Corallo, Salvatore, Fucà, Giovanni, Morano, Federica, Salati, Massimiliano, Spallanzani, Andrea, Gloghini, Annunziata, Volpi, Chiara Costanza, Trupia, Desirè Viola, Lobefaro, Riccardo, Guarini, Vincenzo, Milione, Massimo, Cattaneo, Laura, Antista, Maria, Prisciandaro, Michele, Raimondi, Alessandra, Sposito, Carlo, Mazzaferro, Vincenzo, Braud, Filippo, Pietrantonio, Filippo, Di Bartolomeo, Maria
Format:	Artikel
Sprache:	eng
Schlagworte:	Cohort Studies Epstein-Barr Virus Infections - complications Epstein‐Barr virus infection Gastric cancer Gastrointestinal Cancer Herpesvirus 4, Human Humans Molecular classification Prognosis Stomach Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!